top of page

RESEARCH CENTER
Dermatology

PAID CLINICAL TRIALS

CONTACT US

PREMIER RESEARCH CENTER IN KANSAS

 

KMC Research Center 

Dermatology Division

2921 SW Wanamaker Dr.

Topeka, KS 66614

P: (785) 200-6013

Contact Patti Elliott today!

CURRENT DERMATOLOGY CLINICAL TRIALS

ACELYRIN:
A randomized, double-blind, placebo-controlled, multicenter, phase 3 study to evaluate the efficacy and safety of Izokibep in subjects with moderate to severe Hidradenititis Suppurativa (HS)

Inclusion Criteria:

  • Subject must be ≥ 18 (or the legal age of consent in the jurisdiction in which the study is taking place) and ≤ 75 years of age, at the time of signing the informed consent.

  • Diagnosis of HS for ≥ 6 months prior to first dose of study drug.

HIDRADENITIS SUPPURATIVA (HS)
Screenshot 2024-01-24 082048.png

Success! Message received.

bottom of page